TCID (4,5,6,7-Tetrachloroindan-1,3-dione) is a potent and selective neuronal ubiquitin C-terminal hydrolase (UCH-L3) inhibitor with an IC50 of 0.6 μM. TCID diminishes glycine transporter GlyT2 ubiquitination in brainstem and spinal cord primary neurons.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 67 | |
4 mg | In stock | $ 113 | |
8 mg | In stock | $ 169 | |
20 mg | In stock | $ 366 | |
40 mg | In stock | $ 556 |
Description | TCID (4,5,6,7-Tetrachloroindan-1,3-dione) is a potent and selective neuronal ubiquitin C-terminal hydrolase (UCH-L3) inhibitor with an IC50 of 0.6 μM. TCID diminishes glycine transporter GlyT2 ubiquitination in brainstem and spinal cord primary neurons. |
Targets&IC50 | UCH-L3:0.6 μM |
In vitro | TCID (4,5,6,7-Tetrachloroindan-1,3-dione; compound 11) inhibits UCH-L1 with an IC50 of 75 μM. TCID (10 μM; 1, 2 hours) diminishes glycine transporter GlyT2 ubiquitination in brainstem and spinal cord primary neurons. |
Synonyms | UCH-L3 Inhibitor |
CAS No. | 30675-13-9 |
Chemical Formula | C9H2Cl4O2 |
Molecular Weight | 283.91 |
Solubility | DMSO: 100 mg/mL (296.45 mM), Need ultrasonic |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom